Press release
Peptide CDMO (Pharmaceutical) Market Report- Expansive Coverage on the Profit Sources
According to the latest market research report, the global Peptide CDMO (Pharmaceutical) Market Size is valued at 2.5 Bn in 2024 and is predicted to reach 6.6 Bn by the year 2034 at a 10.4% CAGR during the forecast period for 2025-2034.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1202
Peptides, which are short chains of amino acids, play a critical role in addressing unmet medical needs. Peptide-based therapeutics have become integral in the treatment of conditions such as cancer, diabetes, osteoporosis, chronic pain, multiple sclerosis, and HIV. Owing to their distinct therapeutic properties and considerable potential in the contract active pharmaceutical ingredient (API) manufacturing sector, peptide contract development and manufacturing organizations (CDMOs) are emerging as a key segment of the market.
Market growth in the peptide CDMO sector is expected to be driven by factors such as advancements in healthcare infrastructure, expanding therapeutic applications of peptides, rising healthcare expenditures, and the development of innovative peptide design technologies. Additionally, increased utilization of peptides in drug development, growing R&D investments in peptide-based therapies, and the high prevalence of chronic diseases are contributing to market expansion.
Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/1202
Regionally, North America, followed by Europe, is projected to lead the peptide CDMO (pharmaceutical) market during the forecast period (2022-2030), owing to the well-developing CDMOs, availability of peptide synthesis technologies, and the surging demand for peptides and drugs to treat chronic conditions.
Key market players operating in the peptide CDMO (pharmaceutical) market include AmbioPharm, Auspep, Bachem, BCN Peptide, CPC Scientific, CBL- Chemical and Biopharmaceutical Laboratories, ScinoPharm, Olon, Belyntic, Ferring Pharma, Numaferm, Hybio Pharmaceutical, Provepharm life solutions, Enzene Biosciences, Ardena Holding, Stelis Biopharma, Piramal Pharma, Space Peptides PharmaceuticalCreative Peptides, CSBio, Corden Pharma, PolyPeptide, Hybio Pharmaceutical, Peptide Institute, Pepscan, Almac, Chinese Peptide, CreoSalus Inc, Vivitide, Senn Chemicals, Wuxi AppTec, among others.
Key developments in the market:
• In January 2022, CordenPharma collaborated with PeptiSystems, a Swedish-based developer of peptide and oligonucleotide therapeutic process development and manufacturing instruments, to reduce the footprint impact and improve the Process Mass Intensity (PMI) of peptide manufacturing processes.
• In December 2021, Pepscan extended its column purification technology with a mid-sized column packer. This technology significantly reduces purification time and provides optimal flexibility when synthesizing peptides.
• In September 2021, CEM Corporation and AmbioPharm, Inc. partnered to produce GMP peptides for the global market. The partnership will involve an exclusive1 use of CEM's large-scale microwave peptide synthesis technology to produce GMP peptides up to multi-kilogram quantities using proprietary scalable reactors. Also, it will enable rapid and efficient production of peptide new chemical entities (NCE's) using the latest technologies available.
• In July 2021, CordenPharma expanded its peptide manufacturing capacity in CordenPharma Colorado, their GMP API facility in Boulder, CO (US). CordenPharma Colorado is the largest worldwide peptide API producer leading the global peptide market.
Get Specific Chapter/Information From The Report: @ https://www.insightaceanalytic.com/customisation/1202
Market Segments
Global Peptide CDMO (Pharmaceutical) Market, by Scale of Operation, 2025-2034 (Value US$ Mn)
• Preclinical / Clinical
• Commercial
Global Peptide CDMO (Pharmaceutical) Market, by Method Used, 2025-2034 (Value US$ Mn)
• Chemical Synthesis Method
• Non-Chemical Synthesis Method
Global Peptide CDMO (Pharmaceutical) Market, by By Applications, 2025-2034 (Value US$ Mn)
• Peptide Supplements
• Peptide Vaccines
• Peptides as Radio-Theranostic Agents
• Cell Penetrating Peptides (CPPs)
• Affinity Ligands
• Protein Mimics
Global Peptide CDMO (Pharmaceutical) Market, by Synthesis Types, 2025-2034 (Value US$ Mn)
• LPPS
• SPPS
• Mixed Phase
Global Peptide CDMO (Pharmaceutical) Market, by Region, 2025-2034 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Peptide CDMO (Pharmaceutical) Market, by Country, 2025-2034 (Value US$ Mn)
• The U.S.
• Canada
Europe Peptide CDMO (Pharmaceutical) Market, by Country, 2025-2034 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Peptide CDMO (Pharmaceutical) Market, by Country, 2025-2034 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Peptide CDMO (Pharmaceutical) Market, by Country, 2025-2034 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
The Middle East & Africa Peptide CDMO (Pharmaceutical) Market, by Country, 2025-2034 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of the Middle East & Africa
Get More Information :
https://www.insightaceanalytic.com/report/global-peptide-cdmo-pharmaceutical-market-/1202
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide CDMO (Pharmaceutical) Market Report- Expansive Coverage on the Profit Sources here
News-ID: 4259250 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
RNAi Pesticides Market Report on the Untapped Growth Opportunities in the Indust …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "RNAi Pesticides Market"-, By Application (Insect Pest Control, Weed Management, Disease Management, Resistance Management), By Crop Type (Agricultural Application, Non-Agricultural Application), By Product (Tropical RNAi Pesticide, Seed Embedded RANi, Transgenic RNAi, Others), By Formulation (Liquid Formulation, Granular Formulation, Powder Formulation, Others), Industry Trends, and Global Forecasts, 2025-2034 And Segment Revenue and Forecast To 2034."
The RNAi…
Rice Bran Wax Lubricant Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Rice Bran Wax Lubricant Market - (By Grade (Food Grade, Industrial Grade, Pharmaceutical Grade), End-use (Automotive, Food and Beverage, Cosmetics and Personal Care, Pharmaceuticals, Chemicals, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Rice Bran Wax Lubricant Market is valued at US$ 394.6 million…
Returnable Plastic Crate Market Exclusive Report with Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Returnable Plastic Crate Market - (By Capacity (Less than 10 kg, 10 kg to 20 kg, 21 to 35 kg, 36 to 50 kg, Above 50 kg), By Product Type (Stackable, Nestable, Collapsible), By Material (High-Density Polyethylene (HDPE), Polypropylene (P.P.), Others), By Application (Agriculture, Grocery, Dairy, Bakery, Seafood & Meat, Others)), Trends, Industry Competition…
Respiratory Disease Genetic Testing Market Exclusive Report on the Latest Revenu …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Respiratory Disease Genetic Testing Market- (By Offerings (Products (Kits and Consumables), Services, Others), By Disease Type (COPD (Alpha-1-antitrypsin (AAT), Cystic Fibrosis (CF), Diffuse Lung Disease/Surfactant Dysfunction (RHD (Respiratory Distress Syndrome), PPHN (Persistent Pulmonary Hypertension of the Newborn)), Interstitial lung disease, Pulmonary Arterial Hypertension, Pulmonary Hypoplasia, Primary Ciliary Dyskinesia, Other Diseases (BPD)), By Offerings (PCR, NGS…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
